Carillon Tower Advisers’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Carillon Tower Advisers's LLY Position: Q4 2020 in Review
Carillon Tower Advisers reduced its Eli Lilly (LLY) stake by 0.65% in Q4 2020, selling an estimated $134K and leaving 137,629 shares worth $23.2M. The position accounts for 0.14% of the portfolio, ranked #214.
Carillon Tower Advisers first reported a position in LLY in Q4 2018 and has held it in 9 quarters since. 1,887 funds tracked by Wall St. Rank hold LLY as of Q4 2020.
- Carillon Tower Advisers held 137,629 shares of Eli Lilly worth $23.2M as of Q4 2020.
- Carillon Tower Advisers sold 900 Eli Lilly shares in Q4 2020, an estimated $134K.
- Eli Lilly made up 0.14% of Carillon Tower Advisers's portfolio in Q4 2020, its #214 holding.
- Carillon Tower Advisers first reported a position in Eli Lilly in Q4 2018 and has held it in 9 quarters since.
- 1,887 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2020.
Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.